文献速递肿瘤 PET/CT

前列腺特异性膜抗原PET显像与免疫组化在腺样囊性癌中的初步分析

Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma- a preliminary analysis.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-06-07

该回顾性分析纳入9例头颈部腺样囊性癌(AdCC)患者,分析PSMA PET/CT对AdCC的显示情况,并用免疫组化检测原发、复发和转移灶中PSMA的表达。所有PET/CT均显示PSMA配体摄取,复发和转移灶的中位SUVmax分别为2.52和4.01;所有原发肿瘤及可获得的复发和转移标本均显示PSMA表达。

要点

  • 9例AdCC患者的PSMA PET/CT均显示PSMA配体摄取。
  • 局部复发和远处转移的中位SUVmax分别为2.52和4.01。
  • 所有原发肿瘤及可获得的复发和转移标本均显示PSMA表达。

核心结论

  • PSMA PET/CT能够检测并显示局部复发和远处转移性AdCC,PSMA特异性靶向得到免疫组化PSMA表达的支持。

研究设计与样本

  • 回顾性分析纳入9例头颈部腺样囊性癌(AdCC)患者,分析PSMA PET/CT对AdCC的显示情况,并用免疫组化检测原发、复发和转移AdCC肿瘤组织中PSMA的表达。

主要发现

  • 6例患者发生局部复发,8例发生远处转移。
  • 所有PSMA PET/CT均显示PSMA配体摄取。
  • 4次PSMA PET/CT显示疑似残留病灶,8次扫描显示疑似远处转移区域摄取。
  • 局部复发和远处转移性AdCC的中位SUVmax分别为2.52(IQR 2.41-5.95)和4.01(IQR 2.66-8.71)。
  • 所有原发肿瘤免疫组化均显示PSMA表达(表达率5-90%),所有可获得的局部复发和远处转移标本亦均显示PSMA表达。

关键数值与推荐

  • 局部复发性AdCC的中位SUVmax为2.52(IQR 2.41-5.95)。
  • 远处转移性AdCC的中位SUVmax为4.01(IQR 2.66-8.71)。
  • 原发肿瘤PSMA免疫组化表达率为5-90%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Adenoid cystic carcinoma (AdCC) of the head and neck is an uncommon malignant epithelial tumour of the secretory glands. Many patients develop slowly growing local recurrence and/or distant metastasis, for which treatment options are limited. A retrospective analysis of 9 AdCC patients was conducted to analyse the visualization of AdCC on PSMA PET/CT and to investigate the expression of PSMA on primary, recurrent and metastatic AdCC tumour tissue using immunohistochemistry. RESULTS: Local recurrence occurred in six patients and eight developed distant metastasis. All PET/CTs depicted PSMA-ligand uptake. Four PSMA PET/CTs showed suspected residual disease, eight scans depicted uptake in areas suspected of distant metastasis. Median Maximum Standardized Uptake Value (SUVmax) in local recurrent and distant metastatic AdCC was 2.52 (IQR 2.41-5.95) and 4.01 (IQR 2.66-8.71), respectively. All primary tumours showed PSMA expression on immunohistochemistry (5-90% expression), as well as all available specimens of local recurrence and distant metastases. CONCLUSION: PSMA PET/CT is able to detect and visualize local recurrent and distant metastatic AdCC. PSMA-specific targeting is supported by PSMA expression on immunohistochemistry.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Klein Nulent TJW, van Es RJJ, Krijger GC, et al. Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma- a preliminary analysis. Eur J Nucl Med Mol Imaging. 2017. PMID: 28593386. doi:10.1007/s00259-017-3737-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。